New Corporate Brochure

Heart Transplantation (HTx) remains, despite ongoing challenges such as donor scarcity and long-term graft deterioration, the gold-standard, life-saving treatment for selected patients with end-stage heart

Chronic Kidney Disease (CKD) is estimated to affect around 10% of the global population, yet up to one-third of cases remain undiagnosed. Since genetic testing is increasingly

We’re proud to share that 4bases presented a scientific poster introducing InnoGraft — our innovative, minimally invasive solution for monitoring graft rejection in organ transplant patients. Congrats and thanks